James Poole competitive analysis

Explore patent oppositions filed by James Poole against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 5, 2026
Patent NumberTitleApplicantOpposition Date
Fused Imidazole Derivative, Preparation Method Therefor, And Medical Use ThereofJIANGSU HENGRUI PHARMACEUTICALSOct 28, 2026
Method For Producing Modified Oligonucleotide Including Complementary SequenceAJINOMOTOOct 19, 2026
Methods For Screening Biological Samples For ContaminationINGURANSep 30, 2026
Computer-Implemented Methods For Training A Neural Network Device And Corresponding Methods For Generating A Fragrance Or Flavor CompositionsFIRMENICHJul 8, 2026
Asymmetric Faced Composite Nonwoven Textile And Methods Of Manufacturing The SameNIKE INNOVATE CVJun 24, 2026
Complex Of Nucleic Acid Medicine And Multibranched LipidSHIONOGIJun 15, 2026
Oxytocin Receptor Antagonist Therapy In The Luteal Phase For Implantation And Pregnancy In Women Undergoing Assisted Reproductive TechnologiesFERRINGApr 9, 2026
Identification And Use Of Circulating Nucleic Acid Tumor MarkersTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITYApr 2, 2026
Methods And Systems For Genomic AnalysisPERSONALISJan 29, 2026
Implantable Embolization DeviceCOVIDIEN LPJan 16, 2026

Latest PTAB cases involving James Poole

Discover the latest PTAB cases involving James Poole, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing James Poole with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 5, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
JAMES POOLE207 - - -
AMGEN14165811
MASSACHUSETTS INSTITUTE OF TECHNOLOGY - 136 - 16
PRESIDENT AND FELLOWS OF HARVARD COLLEGE - 135 - 8